| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.5M | -55.7% |
| Cost of Revenue | $1.7M | +8.1% |
| R&D Expense | $29.4M | -20.4% |
| SG&A Expense | $14.4M | -9.7% |
| Operating Income | -$36.9M | -5.1% |
| Income Tax | $0 | — |
| Net Income | -$27.6M | +21.8% |
| EPS (Basic) | -$1.05 | +32.3% |
| EPS (Diluted) | -$1.20 | +22.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.4M | -34.7% |
| Accounts Receivable | $1.3M | -63.2% |
| Inventory | $2.2M | +5.0% |
| Current Assets | $34.7M | -32.5% |
| Total Assets | $45.2M | -24.8% |
| Current Liabilities | $27.0M | -20.6% |
| Long-term Debt | $16.7M | -21.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.4M | -31.0% |
| Capital Expenditures | $52K | -53.2% |
| Investing Cash Flow | -$1.2M | -105.9% |
| Financing Cash Flow | $20.5M | — |
| Free Cash Flow | -$34.5M | -30.6% |
| Stockholders' Equity |
| $14.8M |
| -40.8% |